The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study.
Publication date
2009-11-25T10:26:10ZAuthor
Steward, W.P.Middleton, M.
Benghiat, A.
Loadman, Paul M.
Hayward, C.
Walter, S.
Ford, S.
Halbert, G.
Patterson, Laurence H.
Talbot, D.
Peer-Reviewed
Yes